| # | Drug | Count |
|---|---|---|
| 0 | CABOZANTINIB | 8 |
| 1 | GABAPENTIN | 5 |
| 2 | METHOTREXATE | 5 |
| 3 | METHOTREXATE SODIUM | 5 |
| 4 | ADALIMUMAB | 4 |
| 5 | AMITRIPTYLINE HYDROCHLORIDE | 4 |
| 6 | ESCITALOPRAM | 4 |
| 7 | ESCITALOPRAM OXALATE | 4 |
| 8 | ESCITSLOPRAM | 4 |
| 9 | ETANERCEPT | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 1 | MITOMYCIN | 1 | 0.0003 |
| 2 | UBLITUXIMAB | 1 | 0.0003 |
| 3 | BAYER ASPIRIN EXTRA STRENGTH | 1 | 0.0003 |
| 4 | IDURSULFASE | 1 | 0.0003 |
| 5 | HYDROXOCOBALAMIN | 1 | 0.0002 |
| 6 | AMITRIPTYLINE HYDROCHLORIDE | 4 | 0.0002 |
| 7 | DOCUSATE CALCIUM | 1 | 0.0002 |
| 8 | CABOZANTINIB | 8 | 0.0002 |
| 9 | TOLTERODINE TARTRATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 3 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 9 | Anti-IgE [EPC] | 2 | 0.0000 |